摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5S)-5-[(2S)-butan-2-yl]oxolan-2-one

中文名称
——
中文别名
——
英文名称
(5S)-5-[(2S)-butan-2-yl]oxolan-2-one
英文别名
——
(5S)-5-[(2S)-butan-2-yl]oxolan-2-one化学式
CAS
——
化学式
C8H14O2
mdl
——
分子量
142.2
InChiKey
VBVXMQSVIFHPRP-BQBZGAKWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • NOVEL SUBSTITUTED AMINOTHIAZOLOPYRIMIDINEDIONE FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION
    申请人:Hoffmann-La Roche Inc.
    公开号:US20180093999A1
    公开(公告)日:2018-04-05
    The present invention relates to compounds of formula (I), wherein R 1 to R 5 are as described herein, and their prodrugs or pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
  • Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
    申请人:Hoffmann-La Roche Inc.
    公开号:US20180118763A1
    公开(公告)日:2018-05-03
    The present invention relates to compounds of formula (I), wherein R 1 to R 4 are as described herein, and their prodrugs or pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
  • [EN] 3-SUBSTITUTED 5-AMINO-6H-THIAZOLO[4,5-D]PYRIMIDINE-2,7-DIONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION<br/>[FR] COMPOSÉS 5-AMINO-6H-THIAZOLO [4,5-D]POUR LE TRAITEMENT ET LA PROPHYLAXIDE D'INFECTIONS VIRALES
    申请人:HOFFMANN LA ROCHE
    公开号:WO2016091698A1
    公开(公告)日:2016-06-16
    The present invention relates to compounds of formula (I), wherein R1, R2and R3are as described herein, and their prodrugs or pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds as TLR7 agonists for the treatment and prophylaxis of virus infections.
查看更多